Latest from NORC
Cardiorespiratory fitness that results from activities such as running, walking and cycling has proved to decrease one’s risk of cardiovascular-related disease and death. However, most studies focus on cardiorespiratory fitness levels in midlife, typically in people ages 45 to 64.
The University of Alabama at Birmingham’s Wendy Demark-Wahnefried, Ph.D., professor and Webb Endowed Chair of Nutrition Sciences in the School of Health Professions, was awarded the 2023 Joseph F. Fraumeni, Jr. Distinguished Achievement Award from the American Society of Preventive Oncology.
The new year often brings new resolutions, the majority of which are centered around physical health or weight loss, research shows. Diet and nutrition fads flood the internet with promises of quick weight loss, but many dieters find the regimens difficult to maintain.
A researcher at the University of Alabama at Birmingham Department of Pathology has received an R21 award from the National Institute on Alcohol Abuse and Alcoholism. This grant will be used to better understand whether disruptions in circadian rhythm can negatively influence liver health and whether these disruptions are risk factors for alcohol-related liver disease.
Nearly half of all American adults have elevated blood pressure or hypertension. High blood pressure contributes to 65 percent of cardiovascular deaths in the United States. Exponential advances in genomic sequencing technology have enabled scientists to read the 3.4 billion letters that make up an individual’s DNA in a short period of time and utilize this information for research purposes.
The University of Alabama at Birmingham Department of Family and Community Medicine’s Vice Chair for Research Tapan Mehta, Ph.D., is partnering with investigators at the University of Mississippi Medical Center to lead a $3.6 million study to develop a sustainable and effective Type 2 diabetes management intervention in adults who have Type 2 diabetes and sub-optimal social determinants of health.
The NORC and the UAB Department of Microbiology together named Lyse Norian, PhD, DNS associate professor, and Jeremy Foote, DVM, PhD, associate professor of microbiology, recipients of a $50,000 2022–2023 pilot award for their application “Targeted Inhibition of Oncogenic KRAS in Lean and Obese Pancreatic Ductal Adenocarcinoma Tumor Immune Microenvironment.” The goal of the pilot award is encourage partnerships between Microbiology and the NORC.
Researchers at the University of Alabama at Birmingham are recruiting participants for a new study that investigates whether intermittent fasting or calorie restriction, i.e., losing weight, can slow the aging process and make people younger.
New research presented by University of Alabama at Birmingham researchers shows that a 2.4mg dose of the obesity drug semaglutide can reduce the risk of Type 2 diabetes, or T2D, by 60 percent.